• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FragMAX:MAX IV 实验室的碎片筛选平台。

FragMAX: the fragment-screening platform at the MAX IV Laboratory.

机构信息

BioMAX, MAX IV Laboratory, Fotongatan 2, 224 84 Lund, Sweden.

Department of Biology and Lund Protein Production Platform, Lund University, Sölvegatan 35, 22362 Lund, Sweden.

出版信息

Acta Crystallogr D Struct Biol. 2020 Aug 1;76(Pt 8):771-777. doi: 10.1107/S205979832000889X. Epub 2020 Jul 27.

DOI:10.1107/S205979832000889X
PMID:32744259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7397489/
Abstract

Advances in synchrotron storage rings and beamline automation have pushed data-collection rates to thousands of data sets per week. With this increase in throughput, massive projects such as in-crystal fragment screening have become accessible to a larger number of research groups. The quality of support offered at large-scale facilities allows medicinal chemistry-focused or biochemistry-focused groups to supplement their research with structural biology. Preparing the experiment, analysing multiple data sets and prospecting for interesting complexes of protein and fragments require, for both newcomers and experienced users, efficient management of the project and extensive computational power for data processing and structure refinement. Here, FragMAX, a new complete platform for fragment screening at the BioMAX beamline of the MAX IV Laboratory, is described. The ways in which users are assisted in X-ray-based fragment screenings and in which the fourth-generation storage ring available at the facility is best exploited are also described.

摘要

同步辐射储存环和光束线自动化的进步将数据采集率提高到了每周数千个数据集。随着吞吐量的增加,像在晶体中进行碎片筛选这样的大规模项目已经能够被更多的研究小组所接受。大型设施提供的支持质量使得专注于药物化学或生物化学的小组能够将结构生物学纳入他们的研究中。对于新手和有经验的用户来说,准备实验、分析多个数据集以及寻找蛋白质和碎片的有趣复合物,都需要有效地管理项目,并需要大量的计算能力来进行数据处理和结构精修。这里描述了一种新的完整的用于 MAX IV 实验室 BioMAX 光束线的基于 X 射线的碎片筛选平台——FragMAX。同时还介绍了如何协助用户进行基于 X 射线的碎片筛选,以及如何充分利用该设施中提供的第四代储存环。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/7397489/fa1e1c25dbdb/d-76-00771-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/7397489/ab4f0f6afa9b/d-76-00771-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/7397489/6b2b4665d756/d-76-00771-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/7397489/398ae2788156/d-76-00771-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/7397489/c653c5e66c8a/d-76-00771-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/7397489/fa1e1c25dbdb/d-76-00771-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/7397489/ab4f0f6afa9b/d-76-00771-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/7397489/6b2b4665d756/d-76-00771-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/7397489/398ae2788156/d-76-00771-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/7397489/c653c5e66c8a/d-76-00771-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/7397489/fa1e1c25dbdb/d-76-00771-fig5.jpg

相似文献

1
FragMAX: the fragment-screening platform at the MAX IV Laboratory.FragMAX:MAX IV 实验室的碎片筛选平台。
Acta Crystallogr D Struct Biol. 2020 Aug 1;76(Pt 8):771-777. doi: 10.1107/S205979832000889X. Epub 2020 Jul 27.
2
BioMAX - the first macromolecular crystallography beamline at MAX IV Laboratory.BioMAX——马克斯·四型实验室的第一条大分子晶体学光束线。
J Synchrotron Radiat. 2020 Sep 1;27(Pt 5):1415-1429. doi: 10.1107/S1600577520008723. Epub 2020 Aug 5.
3
FragMAXapp: crystallographic fragment-screening data-analysis and project-management system.FragMAXapp:晶体碎片筛选数据分析和项目管理系统。
Acta Crystallogr D Struct Biol. 2021 Jun 1;77(Pt 6):799-808. doi: 10.1107/S2059798321003818. Epub 2021 May 14.
4
AutoDrug: fully automated macromolecular crystallography workflows for fragment-based drug discovery.自动药物:用于基于片段的药物发现的全自动大分子晶体学工作流程。
Acta Crystallogr D Biol Crystallogr. 2013 May;69(Pt 5):796-803. doi: 10.1107/S0907444913001984. Epub 2013 Apr 11.
5
Fast fragment- and compound-screening pipeline at the Swiss Light Source.瑞士光源的快速片段筛选和组合筛选流水线。
Acta Crystallogr D Struct Biol. 2022 Mar 1;78(Pt 3):328-336. doi: 10.1107/S2059798322000705. Epub 2022 Feb 21.
6
Fast fragment and compound screening pipeline at the Swiss Light Source.瑞士光源的快速片段和化合物筛选流水线。
Methods Enzymol. 2023;690:235-284. doi: 10.1016/bs.mie.2023.08.005. Epub 2023 Sep 12.
7
Fully Autonomous Characterization and Data Collection from Crystals of Biological Macromolecules.生物大分子晶体的全自动表征与数据收集
J Vis Exp. 2019 Mar 22(145). doi: 10.3791/59032.
8
The Automated Crystallography Pipelines at the EMBL HTX Facility in Grenoble.格勒诺布尔欧洲分子生物学实验室 HTX 设施的自动化晶体学管道。
J Vis Exp. 2021 Jun 5(172). doi: 10.3791/62491.
9
Automation of the EMBL Hamburg protein crystallography beamline BW7B.欧洲分子生物学实验室汉堡蛋白质晶体学光束线BW7B的自动化
J Synchrotron Radiat. 2004 Sep 1;11(Pt 5):372-7. doi: 10.1107/S090904950401516X. Epub 2004 Aug 17.
10
X-CHIP: an integrated platform for high-throughput protein crystallization and on-the-chip X-ray diffraction data collection.X-CHIP:用于高通量蛋白质结晶和芯片上X射线衍射数据收集的集成平台。
Acta Crystallogr D Biol Crystallogr. 2011 Jun;67(Pt 6):533-9. doi: 10.1107/S0907444911011589. Epub 2011 May 12.

引用本文的文献

1
Project automation in CCP4 Cloud: Enabling customization and high-throughput efficiency.CCP4云平台中的项目自动化:实现定制化与高通量效率。
Protein Sci. 2025 Jun;34(6):e70176. doi: 10.1002/pro.70176.
2
Where and how to house big data on small fragments.在小片段上存储大数据的位置及方式。
Nat Commun. 2025 May 5;16(1):4179. doi: 10.1038/s41467-025-59233-z.
3
Status and perspective of protein crystallography at the first multi-bend achromat based synchrotron MAX IV.基于首个多弯铁消色差器的同步加速器MAX IV的蛋白质晶体学现状与展望。

本文引用的文献

1
F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.F2X-Universal 和 F2X-Entry:用于晶体筛选的结构多样的化合物库。
Structure. 2020 Jun 2;28(6):694-706.e5. doi: 10.1016/j.str.2020.04.019. Epub 2020 May 14.
2
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
3
Design of a Fragment-Screening Library.片段筛选文库的设计
J Synchrotron Radiat. 2025 May 1;32(Pt 3):779-791. doi: 10.1107/S1600577525002255. Epub 2025 Apr 4.
4
Structural Biology for Target Identification and Validation.用于靶点识别与验证的结构生物学
Methods Mol Biol. 2025;2905:17-49. doi: 10.1007/978-1-0716-4418-8_2.
5
Macromolecular crystallography at SPring-8 and SACLA.在日本兵库县的SPring-8和日本埼玉县的SACLA进行的大分子晶体学研究。
J Synchrotron Radiat. 2025 Mar 1;32(Pt 2):304-314. doi: 10.1107/S1600577525000657. Epub 2025 Feb 18.
6
Macromolecular crystallography from an industrial perspective - the impact of synchrotron radiation on structure-based drug discovery.从工业角度看大分子晶体学——同步辐射对基于结构的药物发现的影响。
J Synchrotron Radiat. 2025 Mar 1;32(Pt 2):294-303. doi: 10.1107/S1600577524012281. Epub 2025 Feb 6.
7
Development of a Crystallographic Screening to Identify Sudan Virus VP40 Ligands.用于鉴定苏丹病毒VP40配体的晶体学筛选方法的开发。
ACS Omega. 2024 Jul 18;9(30):33193-33203. doi: 10.1021/acsomega.4c04829. eCollection 2024 Jul 30.
8
Upgrade of crystallography beamline BL19U1 at the Shanghai Synchrotron Radiation Facility.上海同步辐射装置晶体学光束线BL19U1的升级
J Appl Crystallogr. 2024 Apr 15;57(Pt 3):630-637. doi: 10.1107/S1600576724002188. eCollection 2024 Jun 1.
9
HEIDI: an experiment-management platform enabling high-throughput fragment and compound screening.HEIDI:一个支持高通量片段和化合物筛选的实验管理平台。
Acta Crystallogr D Struct Biol. 2024 May 1;80(Pt 5):328-335. doi: 10.1107/S2059798324002833. Epub 2024 Apr 12.
10
Fragment-based screening targeting an open form of the SARS-CoV-2 main protease binding pocket.基于片段的筛选,针对 SARS-CoV-2 主蛋白酶结合口袋的开放形式。
Acta Crystallogr D Struct Biol. 2024 Feb 1;80(Pt 2):123-136. doi: 10.1107/S2059798324000329. Epub 2024 Jan 30.
Methods Enzymol. 2018;610:97-115. doi: 10.1016/bs.mie.2018.09.018. Epub 2018 Oct 19.
4
Current perspectives in fragment-based lead discovery (FBLD).基于片段的药物发现(FBLD)的当前观点。
Essays Biochem. 2017 Nov 8;61(5):453-464. doi: 10.1042/EBC20170028.
5
A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density.多晶体法从传统上无法解释的电子密度中提取隐藏的晶体状态。
Nat Commun. 2017 Apr 24;8:15123. doi: 10.1038/ncomms15123.
6
Soaking suggests "alternative facts": Only co-crystallization discloses major ligand-induced interface rearrangements of a homodimeric tRNA-binding protein indicating a novel mode-of-inhibition.浸泡实验暗示了“另类事实”:只有共结晶实验揭示了同二聚体tRNA结合蛋白在主要配体诱导下的界面重排,这表明了一种新的抑制模式。
PLoS One. 2017 Apr 18;12(4):e0175723. doi: 10.1371/journal.pone.0175723. eCollection 2017.
7
The XChemExplorer graphical workflow tool for routine or large-scale protein-ligand structure determination.XChemExplorer 图形工作流工具,用于常规或大规模的蛋白质-配体结构测定。
Acta Crystallogr D Struct Biol. 2017 Mar 1;73(Pt 3):267-278. doi: 10.1107/S2059798316020234. Epub 2017 Feb 24.
8
Guidelines for the successful generation of protein-ligand complex crystals.蛋白质-配体复合物晶体生成的成功指南。
Acta Crystallogr D Struct Biol. 2017 Feb 1;73(Pt 2):79-92. doi: 10.1107/S2059798316020271.
9
Biophysics in drug discovery: impact, challenges and opportunities.药物发现中的生物物理学:影响、挑战与机遇。
Nat Rev Drug Discov. 2016 Oct;15(10):679-98. doi: 10.1038/nrd.2016.123. Epub 2016 Aug 12.
10
Twenty years on: the impact of fragments on drug discovery.二十年后:碎片对药物发现的影响。
Nat Rev Drug Discov. 2016 Sep;15(9):605-619. doi: 10.1038/nrd.2016.109. Epub 2016 Jul 15.